Materias dentro de su búsqueda.
Materias dentro de su búsqueda.
Derecho penal
893
Procedimiento penal
534
Leyes y legislación
415
Administración de justicia penal
142
Historia
141
Delitos
74
Juicio oral
65
Criminología
59
Amparo
49
Responsabilidad penal
48
Prisiones
45
Derecho
43
Sistema acusatorio
40
Filosofía
39
Prueba penal
38
Derechos humanos
37
Penas
37
Política y gobierno
34
México
30
Situación legal
28
Derechos civiles
27
Administración de justicia
25
Procedimiento civil
25
Filosofía del derecho penal
24
Derecho constitucional
23
Derecho procesal
23
Jurisprudencia
22
Procesos (Derecho)
22
Aspectos sociales
21
Delitos internacionales
20
-
162281“…Total 95 bucket handle tear cases were enrolled in this study. Patients were analyzed on an average of 27.14 ± 24.8 months after surgery by the use of Marx score (MS) and Tegner Activity Scale (TAS). …”
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
162282por Spence, Michele M., Polzin, Jennifer K., Weisberger, Calvin L., Martin, John P., Rho, Jay P., Willick, Giselle H.“…METHODS: This retrospective cohort study used clinic and enrollment data to identify those patients in the pharmacist-managed program and usual care who received at least 100 days of amiodarone therapy with the first prescription for amiodarone (index) from June 1, 2007, through May 31, 2009 (index date). …”
Publicado 2011
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
162283por Robinson, Rebecca L., Long, Stacy R., Chang, Stella, Able, Stephen, Baser, Onur, Obenchain, Robert, Swindle, Ralph W.“…RESULTS: A total of 60,386 adult patients (10.7%) of 562,898 patients with a depression diagnosis met NCQA inclusion criteria in the AMM Technical Specifications (e.g., aged 18 years or older, newly diagnosed with depression and initiating antidepressant therapy, 365 days of continuous enrollment; patients were excluded if there were missing data on dose or quantity of index drug in pharmacy claims or initiated therapy on 2 or more antidepressants as the index medication, exclusion criteria not in the AMM Technical Specifications). …”
Publicado 2006
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
162284por Newell-Price, John, Pivonello, Rosario, Lacroix, André, Biller, Beverly M K, Feelders, Richard, Gadelha, Mônica, Bertherat, Jérôme, Belaya, Zhanna, Piacentini, Andrea, Pedroncelli, Alberto M, Fleseriu, Maria“…Pts with mUFC >1.5 times the upper limit of normal (ULN) (LINC 2 and LINC 3) or mUFC >1.3 x ULN (LINC 4) were enrolled. In LINC 2, pts started open-label osilodrostat 2 mg twice daily (bid), with dose increases every 2 weeks (W) if mUFC >ULN. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
162285por Zadik, Zvi, Zelinska, Nataliya, Iotova, Violeta, Skorodok, Yulia, Malievskiy, Oleg A, Mauras, Nelly, Valluri, Srinivas R, Pastrak, Aleksandra, Rosenfeld, Ron G, Taylor, Carrie T, Nijher, Monica, Roland, Carl, Wang, Ronnie, Wajnrajch, Michael P, Cara, Jose F“…Subjects were randomized 1:1:1:1 to once-weekly somatrogon (titrated up to 0.25, 0.48, or 0.66 mg/kg/wk) or once-daily Genotropin (0.24 mg/kg/wk) for 12 mo of the main study (periods I and II), after which they were eligible to enroll in the OLE (periods III-V). In period III, somatrogon recipients continued at their previous dose; Genotropin recipients were re-randomized to 1 of the 3 somatrogon doses. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
162286por Savarirayan, Ravi, De Bergua, Josep Maria, Arundel, Paul, Salles, Jean Pierre, Saraff, Vrinda, Delgado, Borja, Leiva-Gea, Antonio, McDevitt, Helen, Nicolino, Marc P, Rossi, Massimiliano, Salcedo, Maria, Cormier-Daire, Valerie, Skae, Mars, Kannu, Peter, Bober, Michael B, Phillips, John, Saal, Howard, Harmatz, Paul, Burren, Christine Pamela, Candler, Toby, Cho, Terry, Muslimova, Elena, Weng, Richard, Raj, Supriya, Hoover-Fong, Julie, Irving, Melita, Rogoff, Daniela“…Other parameters of disease burden are evaluated as exploratory endpoints. Summary: Children enrolled in the PROPEL 2 DE phase completed ≥6 months of treatment at the assigned cohort dose. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
162287por Gupta, Shaloo, Chang, Nai-Chung N, Stempniewicz, Nikita, Tirupati, Chenchu Bhavani K, Coronado, Gregorio, Lynch, Julie A, Hogea, Cosmina, Mulvihill, Emily, Gagner, Jason, DuVall, Scott L“…Respondents were indexed on their HZ diagnosis and included if aged 18-70 years, reported working for pay at index, and had 6 months of baseline continuous enrollment. Respondents were excluded if they had a baseline HZ vaccine, did not complete the survey within 30 days after index, or reported not having HZ or experiencing a rash > 14 days prior to index. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
162288por Radeva‐Petrova, Denitsa, Kayentao, Kassoum, ter Kuile, Feiko O, Sinclair, David, Garner, Paul“…MAIN RESULTS: Seventeen trials enrolling 14,481 pregnant women met our inclusion criteria. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
162289“…Price subsidies ranged from 80% to 95%. One trial enrolled children under five years of age; the other three trials studied people of all age groups. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
162290por Krasimirova, Ekaterina, Velikova, Tsvetelina, Ivanova-Todorova, Ekaterina, Tumangelova-Yuzeir, Kalina, Kalinova, Desislava, Boyadzhieva, Vladimira, Stoilov, Nikolay, Yoneva, Tsvetelina, Rashkov, Rasho, Kyurkchiev, Dobroslav“…AIM: To investigate T-cell activation, the percentage of peripheral T regulatory cells (Tregs), Th17 cells and the circulating cytokine profile in systemic sclerosis (SSc). METHODS: We enrolled a total of 24 SSc patients and 16 healthy controls in the study and divided the patients as having diffuse cutaneous SSc (dcSSc, n = 13) or limited cutaneous SSc (lcSSc, n = 11). …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
162291“…A total of 23 trials met the inclusion criteria, enrolling more than 275,793 adults and children. The included studies were conducted between 1987 and 2001. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
162292por Camarata, Laura, Juraschek, Stephen P., Sheff, Pamela, Doyle, Peter A., Graham, Robert M., Adamovich, John M., Paine, Lori A., Miller III, Edgar R.“…The initial cohort was 24 masters students enrolled in the JHU Whiting School of engineering, and included 46% men, 54% women, and 75% international students. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
162293por Iwata, Nakao, Ishigooka, Jun, Naoi, Ichiro, Matsumoto, Masahiro, Kanamori, Yuichi, Nakamura, Hiroshi, Higuchi, Teruhiko“…METHODS: An open-label study was conducted in adults with schizophrenia at 37 sites in Japan. Patients were enrolled in either cohort 1 or 2. Patients in cohort 1 received 8–16 mg/day blonanserin tablets for 6 weeks and then 40–80 mg/day blonanserin patches for 52 weeks. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
162294por Patil, Avinash S, Gaikwad, Nilesh W, Grotegut, Chad A, Dowden, Shelley D, Haas, David M“…Women participating in the IU BBPB who were enrolled after 8 weeks’ gestation with pregnancy outcome data were eligible for participation. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
162295por Gorman, Ellen, Shankar-Hari, Manu, Hopkins, Phil, Tunnicliffe, William S., Perkins, Gavin D., Silversides, Jonathan, McGuigan, Peter, Jackson, Colette, Boyle, Roisin, McFerran, Jamie, McDowell, Cliona, Campbell, Christina, McFarland, Margaret, Smythe, Jon, Thompson, Jacqui, Williams, Barry, Curley, Gerard, Laffey, John G., Clarke, Mike, O’Kane, Cecilia, McAuley, Daniel F.“…Patients will be excluded for the following reasons: more than 72 hours from the onset of ARDS; age < 16 years; patient known to be pregnant; major trauma in previous 5 days; presence of any active malignancy (other than non-melanoma skin cancer); WHO Class III or IV pulmonary hypertension; venous thromboembolism currently receiving anti-coagulation or within the past 3 months; patient receiving extracorporeal life support; severe chronic liver disease (Child-Pugh > 12); Do Not Attempt Resuscitation order in place; treatment withdrawal imminent within 24 hours; prisoners; declined consent; non-English speaking patients or those who do not adequately understand verbal or written information unless an interpreter is available; previously enrolled in the REALIST trial. INTERVENTION AND COMPARATOR: Intervention: Allogeneic donor CD362 enriched human umbilical cord derived mesenchymal stromal cells (REALIST ORBCEL-C) supplied as sterile, single-use cryopreserved cell suspension of a fixed dose of 400 x10(6) cells in 40ml volume, to be diluted in Plasma-Lyte 148 to a total volume of 200mls for administration. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
162296por Barnabas, Ruanne V., Brown, Elizabeth, Bershteyn, Anna, Miller, R. Scott, Wener, Mark, Celum, Connie, Wald, Anna, Chu, Helen, Wesche, David, Baeten, Jared M.“…PARTICIPANTS: This study will enroll up to 2000 asymptomatic adults 18 to 80 years of age (inclusive) at baseline who are close contacts of persons with polymerase chain reaction (PCR)-confirmed SARS-CoV-2 or clinically suspected COVID-19 and a pending SARS-CoV-2 PCR test. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
162297por Garcia-Vicuña, Rosario, Abad-Santos, Francisco, González-Alvaro, Isidoro, Ramos-Lima, Francisco, Sanz, Jesús Sanz“…Duration of hospitalisation: Days from the date of enrolment to the date of discharge 3. Number of deaths at the end of study RANDOMISATION: Randomisation to treatment arms sarilumab plus standard of care or standard of care in a 2:1 ratio will be performed by the Clinical Research and Clinical Trials Unit (CRCTU) at the Hospital using a table of random numbers, an internet-based randomisation tool. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
162298por Ishola, David, Manno, Daniela, Afolabi, Muhammed O, Keshinro, Babajide, Bockstal, Viki, Rogers, Baimba, Owusu-Kyei, Kwabena, Serry-Bangura, Alimamy, Swaray, Ibrahim, Lowe, Brett, Kowuor, Dickens, Baiden, Frank, Mooney, Thomas, Smout, Elizabeth, Köhn, Brian, Otieno, Godfrey T, Jusu, Morrison, Foster, Julie, Samai, Mohamed, Deen, Gibrilla Fadlu, Larson, Heidi, Lees, Shelley, Goldstein, Neil, Gallagher, Katherine E, Gaddah, Auguste, Heerwegh, Dirk, Callendret, Benoit, Luhn, Kerstin, Robinson, Cynthia, Leyssen, Maarten, Greenwood, Brian, Douoguih, Macaya, Leigh, Bailah, Watson-Jones, Deborah“…FINDINGS: Between Sept 30, 2015, and Oct 19, 2016, 443 participants (43 in stage 1 and 400 in stage 2) were enrolled; 341 participants assigned to receive the Ad26.ZEBOV and MVA-BN-Filo regimen and 102 participants assigned to receive the MenACWY and placebo regimen received at least one dose of study vaccine. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
162299por Zeng, Congcong, Yuan, Zhengzhong, Pan, Xiaoqiong, Zhang, Jizhou, Zhu, Jiahui, Zhou, Fan, Shan, Zhuocheng, Yuan, Ye, Ye, Ren, Cheng, Jinguo“…Signed the informed consent before treatment. 2. Agreed not to enroll in any other clinical trials. 3. Inpatients Exclusion criteria 1. < 18 or > 85 years old. 2. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
162300por Arribas, Jose Ramon, Arribas, Jose Ramon, Sanyal, Arun J, Soriano, Alex, Chin, Bum Sik, Chin, Bum Sik, Kalimuddin, Shirin, Schreiber, Stefan, Elboudwarej, Emon, Tian, Yuan, Hyland, Robert H, SenGupta, Devi, Chokkalingam, Anand, Osinusi, Anu, Brainard, Diana M, Lübbert, Christoph, Lye, David Chien Boon, Lye, David Chien Boon, Aberg, Judith A, Elorza, Enrique Navas, Tashima, Karen T, McPhail, Mark“…We report the impact of concomitant HQN and RDV use on clinical outcomes and safety in patients with moderate COVID-19. METHODS: We enrolled hospitalized patients with confirmed SARS-CoV-2 infection, oxygen saturation >94% on room air, and radiological evidence of pneumonia. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Online Artículo Texto